24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
61.01% |
|
CANCER |
18.81% |
|
EBOLA |
12.39% |
|
PEPTIDOMIMETIC CD40L BINDING |
2.75% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
2.75% |
|
ENZYME DYNAMICS |
2.29% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
48.24% |
|
CANCER |
20.54% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
10.27% |
|
PEPTIDOMIMETIC CD40L BINDING |
10.07% |
|
EBOLA |
7.09% |
|
RCA TEMPERATURE SIMULATIONS |
1.86% |
|
ATSTP10 SUCROSE TRANSPORT |
.8% |
|
ATSTP10 TRANSPORT SIMULATION |
.8% |
|
ENZYME DYNAMICS |
.33% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
35.53% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
16.36% |
|
ENZYME DYNAMICS |
13.77% |
|
CANCER |
11.09% |
|
PEPTIDOMIMETIC CD40L BINDING |
6.67% |
|
EBOLA |
5.71% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
2.69% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
2.27% |
|
ATSTP10 SUCROSE TRANSPORT |
1.85% |
|
ATSTP10 TRANSPORT SIMULATION |
1.55% |
|
RCA STABILITY SIMULATIONS |
1.23% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.35% |
|
RCA TEMPERATURE SIMULATIONS |
.34% |
|
ATWRI1 MUTANT SCREENING |
.26% |
|
MEMBRANE TRANSPORT |
.24% |
|
NIPAH VIRUS DECOY PROTEINS |
.09% |